This article explains how FDA pharmaceutical regulations shape global GMP compliance, inspection outcomes, and enforcement actions. It explores FDA inspection findings, data integrity expectations, and evolving regulatory models that impact pharmaceutical quality systems and manufacturing standards worldwide.
